At a glance

ClinicalIndex Comparison Record

N/ACompleted· 12 enrolled

Drug / intervention

Diabetes Assistant (DiAs) with Closed-Loopdevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02750267

NCT02750267N/ACompleted

Compare CT.gov

Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform

University of Virginia·interventional·Posted Apr 25, 2016·Updated Jul 24, 2017

In Brief

A clinical study evaluating Diabetes Assistant (DiAs) with Closed-Loop for Diabetes Mellitus, Type 1. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The overall aim of this proposed research is to determine the safety, feasibility and efficacy (AP vs at home use of SAP) of the Diabetes Assistant (DiAs) controller in day and night closed-loop control in young children 5-8 years old with type 1 diabetes over multiple 48 hours in an out-patient setting.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDiabetes Mellitus, Type 1

CountriesUnited States

CollaboratorsDexCom, Inc.

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

First PostedApr 2016

Enrollment StartMay 2016

Primary CompletionMay 2016

TodayJul 2026

First PostedApr 25, 2016

Enrollment StartMay 1, 2016

Primary CompletionMay 1, 2016

TodayJul 2, 2026

Enrollment to primary: 0 daysPosted 10.2 years ago

Interventions

Diabetes Assistant (DiAs) with Closed-Loopdevice

All subjects will use DiAs Medical Platform, a study insulin pump and continuous glucose monitor (CGM) in closed-loop mode during a Research House/Hotel admission that will last up to 72 hours.